In clinical research, the use of Self-Management Self-Test (SMST) is gaining prominence as a valuable psychiatric tool for evaluating patient autonomy and mental status for the duration of the study.
The SMST scale empowers patients to monitor their own mental health metrics while providing real time data to investigators for patient safety and IP effectiveness.
By integrating SMST into clinical trials, researchers can gather more comprehensive data on patient mental health, improve patient engagement, and potentially increase the safety and completion percentage of participants in the trial.
This patient-centric and decentralized approach not only facilitates better self-care practices but also aligns with the growing trend in precision medicine.